Hakim Echchannaoui
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The Streptomyces Metabolite Thiostrepton Inhibits Regulatory T Cell Differentiation and Function to Boost Antitumor Immune Responses.
Journal: European journal of immunology
Published: June 25, 2025
CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma.
Journal: International journal of molecular sciences
Published: June 10, 2025
Case Report: Late-onset primary hemophagocytic lymphohistiocytosis leading to the diagnosis of Griscelli syndrome type 2 in a young woman with phenotypically inapparent partial albinism.
Journal: Frontiers in immunology
Published: April 01, 2025
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology.
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology.
Journal: Oncology research and treatment
Published: November 06, 2024
Editorial: Translation of genetically engineered T cells in cancer immunotherapy.
Journal: Frontiers in immunology
Published: August 16, 2023
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.
Journal: Haematologica
Published: September 25, 2022
Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: April 25, 2021
Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes.
Journal: Frontiers in immunology
Published: October 15, 2020
Selective elimination of immunosuppressive T cells in patients with multiple myeloma.
Journal: Leukemia
Published: October 13, 2020
Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability.
Journal: Frontiers in oncology
Published: September 13, 2019
A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 28, 2018
Last Updated: 09/26/2026